Last updated on November 2019

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy


Brief description of study

The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in subjects with moderately and severely active Crohn's disease (CD).

Clinical Study Identifier: NCT03345836

Find a site near you

Start Over

Inquest Clinical Research /ID# 164865

Baytown, TX United States
5.44miles
  Connect »